KoreaFilings
L&K Biopharm (KRX: 156100)

L&K Biopharm largest shareholder Kang Guk-jin raises stake to 12.19% via additional purchase

stake_5pct · spotted Aug 3, 2026, 5:40 PM KST

Increase in largest shareholder's voting control from prior undisclosed level to 12.19% affects shareholder composition and potential influence over corporate decisions.

View original DART filing ↗

AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.